Mongolia has the world’s highest rate of liver cancer mortality; nearly eight times the global average. The prevalence of chronic viral hepatitis B, C, and D is at endemic level, and constitutes the main reason cause of Mongolia’s world-leading liver cancer mortality rate. To tackle this deadly crisis, the Onom Foundation, Patient and Civil Society Council, Mongolian Gastroenterology Association, and Mongolian Society of Hepatology launched the Hepatitis Prevention, Control, and Elimination (HPCE).
Registration for the 1st Kidney Meets Liver Meeting in Amsterdam on 16th March 2018 is open!
EASL International Liver Foundation and European Renal Association – European Dialysis and Transplant Association are holding the first Kidney Meets Liver meeting on March 16th 2018 in Amsterdam.
EILF NAFLD Policy Review is Launching this month
With an estimated global prevalence of 25%, Non-alcoholic fatty liver disease (NAFLD) is a global public health epidemic that is not receiving enough attention. The first step to taking a comprehensive public health response to NAFLD is to review the relevant policies and guidelines in place.
New Project alert: Viral Hepatitis Elimination in Migrants
The world is currently experiencing the greatest level of forced displacement that has ever been recorded, and as a result the disease burden profiles in Europe are changing.
Update from Pakistan
EILF delegates, Professor Massimo Colombo (EILF Chairman of the Board), Professor Mark Thursz (EILF Board Member), and Professor Mario Mondelli have recently returned from a productive trip to Pakistan.